Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995 and has six manufacturing facilities in Pakistan and one in France.
History
Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore.
In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.
In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum. In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.
In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France. In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France. The plant of V2Pharm in Gien, France was also taken over by Martin Dow.
In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh local government minister.
Controversy
In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase.
References
↑"Martin Dow Limited"(PDF). The Pakistan Credit Rating Agency Limited. Retrieved 29 May 2025.
↑bhooto, bilawal (21 November 2016). "A strategic relationship". Dawn. Retrieved 31 December 2016. With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
↑"Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.